GlassScriptPhysician profile
Ishrat Quadri
NPI 1528089737
$587.70
in general payments reported to CMS, 2019-2025
9 companies · $125 in 2025
The $125 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.11 · 2020: $78.12 · 2021: $30.72 · 2022: $77.64 · 2023: $102 · 2024: $108 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $130.00 | 2019-2025 | Doc Band |
| Biomerieux INC | $123.94 | 2024-2025 | Biofire Spotfire Control Station, Biofire Spotfire Respiratory (R) Panel |
| Pfizer INC. | $92.03 | 2020-2021 | |
| Glaxosmithkline, LLC. | $69.13 | 2019-2025 | Bexsero, Rotarix, Penmenvy |
| Sobi, INC | $58.59 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $42.76 | 2023-2024 | Vaxelis, Vaxneuvance, Rotateq |
| Phadia US INC. | $28.56 | 2019-2022 | |
| Hologic Sales and Service, LLC | $25.93 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ishrat Quadri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.